Tesamorelin / Ipamorelin Mix is among the peptides researched in the context of the growth hormone (GH) axis. The rationale rests on mechanistic synergy: tesamorelin stimulates the GHRH receptor while ipamorelin stimulates the separate ghrelin receptor on the same somatotroph cells.
Studied to explore whether combined GHRH-receptor and ghrelin-receptor activation produces stronger GH pulses than either peptide alone, drawing on the separately established profiles of each parent peptide.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.
Specific study references will be added for this product. For current literature, independent research (e.g. via PubMed) is recommended.
We reply personally – via email or Telegram.